HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

quinotrierixin

structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 4 or More Rings Heterocyclic Compounds
    - Rifamycins: 416
      - Rifabutin: 648
        quinotrierixin: 1
Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Macrocyclic Lactams: 28
    - Rifamycins: 416
      - Rifabutin: 648
        quinotrierixin: 1

Experts

1.	Chen, Chen: 1 article (01/2013)
2.	Li, Jingming: 1 article (01/2013)
3.	Wang, Joshua J: 1 article (01/2013)
4.	Yu, Qiang: 1 article (01/2013)
5.	Zhang, Sarah X: 1 article (01/2013)

Related Diseases

1.	Proliferative Vitreoretinopathy 01/01/2013 - "Future studies are needed to investigate the in vivo effect of quinotrierixin on RPE proliferation in animal models of proliferative vitreoretinopathy." 01/01/2013 - "Quinotrierixin inhibits RPE cell proliferation and may be used as a novel antiproliferative drug for treating proliferative vitreoretinopathy. "